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Conclusion: Accurate midV-CT can be generated using 
freeware. This opens the prospect for its use in our clinical 
practice, allowing treatments in the upper abdomen with 
more adequate CTV-to-PTV margins. For lung cancer patients 
the approach should work even better due to the higher 
contrast images. 
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Purpose or Objective: Radiotracer uptake patterns in FDG-
PET through computation of textural features vcan be used to 
improve characterization of lung cancer lesions for disease 
prognostication and response monitoring and tumor 
delineation purposes. Respiratory motion artefacts cause 
lesion blurring resulting in loss of intra-tumour 
heterogeneity. We have investigated the effect of respiratory 
gating on the recovery of intra-tumour heterogeneity. 
 
Material and Methods: FDG-PET/CT imaging was performed 
in 70 lung cancer patients. Amplitude-based optimal 
respiratory gating (ORG) was performed on bed positions 
covering the thorax. The duty cycle (percentage of the total 
PET data) used for image reconstruction of ORG images was 
35%. Non-gated images were reconstructed using 126 seconds 
of PET data, yielding similar noise characteristics as ORG. 
Lesion segmentation was performed using the fuzzy locally 
adaptive Bayesian (FLAB) algorithm. Four heterogeneity 
parameters (entropy, dissimilarity, zone percentage (ZP), and 
high energy emphasis (HIE)), which have previously shown to 
be robust and associated with survival in lung cancer, were 
calculated in non-gated and ORG images.  
 
Results: Respiratory gating did not result in statistically 
significant differences in the heterogeneity parameters. Sub-
group analysis revealed a significant effect of ORG on the 
heterogeneity parameters of lesions in the lower lobes. The 
mean increase for entropy, dissimilarity, ZP and HIE, 
considering lesions in the lower lobes was 1.3±1.5% (p=0.02), 
11.6±11.8% (p=0.006) 2.3±2.2% (p=0.002), and 16.8%±17.2% 
(p=0.006) respectively. For the centrally located lesions, the 
mean increase for entropy, dissimilarity, ZP and HIE was 
0.58±3.7% (p=0.6), 5.0±19.0% (p=0.4) 0.59±4.0% (p=0.9), and 
4.4±27.8% (p=0.4), respectively. Lesions in the upper lobes 
showed a mean increase of -0.35±1.8 (p=0.3), -1.0±7.7% 
(p=0.3), -0.4±2.7% (p=0.5), -1.7±13.2% (p=0.4), for entropy 
dissimilarity, ZP and HIE, respectively. There was no 
significant correlation between lesion volume and the change 
in parameters between non-gated and ORG images. 
 
Conclusion: Results from this study indicate that ORG 
significantly impacts characterisation of intra-tumour 
heterogeneity, particularly for lesions in the lower lung 
lobes. This suggests that adequate management of 
respiratory motion artefacts is important for improving 
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Purpose or Objective: Developing a radiobiologically 
consistent model predicting individual outcome for rectal 
cancer patients (RCPs) treated with an adaptive boost 
approach during neo-adjuvant radiochemotherapy (RCH). 
 
Material and Methods: Forty-two RCPs were treated within a 
prospective observational study. CH consisted of oxaliplatin 
(on days: -14, 0, 14) and 5-fluorouroacil (from day -14 to end) 
being day 0 the start of RT. All patients were treated with 
Helical Tomotherapy (18x2.3Gy) with an adaptive 
concomitant boost technique delivering 3Gy/fr on the 
residual gross tumor volume (GTV) in the last 6 fractions (fr), 
based on MRI imaging taken at fr 9. GTVs were contoured by 
a single radiologist on axial T2 MRI images acquired for initial 
planning (V_PRE), at fr 9 for the adaptive planning (V_MID) 
and before surgery, after a median time of 8.9 weeks after 
the end of RCH (V_POST). Based on a Poisson-like tumor 
regression model and neglecting repopulation and inter-
patient variability of the removal kinetics of killed cells, the 
parameter (1-ΔV(D))^V_PRE was taken as a surrogate of 
tumor control probability (TCP), where ΔV(D)=V_MID/V_PRE 
or V_POST/V_PRE, considering D at fr 9 (TCP_MID) or at the 
end of RCH (TCP_POST). The discriminative power of 
TCP_MID/POST in predicting the pathological complete 
remission (pCR, n=14) was assessed by the AUC of the 
corresponding ROC curves. Then, two-variables logistic (LOG) 
models including V_PRE and ΔV(D) as covariates were also 
considered and the ROC curves of the four models 
(TCP_MID,TCP_POST,LOG_MID, LOG_POST) were compared. 
In addition, an estimate of the residual cells at surgery (V_S) 
was robustly taken as the product of the pathologically 
assessed fraction of viable cells and V_POST. Spearman 
correlation rank test was used to evaluate the correlation 
between the models and V_S. 
 
Results: All models showed a high discriminative power in 
predicting pCR (p-value<0.0001). AUCs for TCP_ MID was 0.87 
(specificity: 71.4%, sensitivity: 96.4%, best cut-off: 5.85), 
higher than TCP_POST (0.82), although the difference did not 
reach significance (p=0.18). TCP_MID/TCP_POST were also 
highly correlated with V_S (R=0.77 and 0.74,p<0.0001). 
Similar performances were found for LOG_MID/LOG_POST 
with AUC=0.90/0.87 and R=0.79/0.77. No significant 
differences were found when comparing TCP models against 




Conclusion: A radiobiologically consistent model including 
early regression (TCP_MID) measured on T2-MRI images well 
predicts pCR and is strongly correlated with the estimated 
residual cells number after adaptive RCH; similar 
performances were obtained with a logistic model including 
V_PRE and V_MID/V_PRE. The corresponding models using 
V_POST showed a slightly, statistically not significant, worse 
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discriminative power. The results showed that MRI volumes 
measured before and during RCH have a great potential to 
better individualize adaptive RCH. 
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Purpose or Objective: Dynamic contrast enhanced (DCE) MRI 
is becoming an increasingly important tool for assessing 
tumour response in Radiotherapy (RT). Important 
characteristics are spatial and temporal resolution and in 
lung this is further complicated by the effects of respiratory 
motion. A common approach is to acquire fast gradient-echo 
imaging utilising k-space sharing to provide optimum 
temporal resolution and to collect data during short 
‘windows’ of breath-holds over the time course. However 
patient compliance during breath hold manoeuvres can lead 
to tumour displacement and introduce error in analysis. 
Radial acquisitions can alleviate motion by oversampling the 
centre of k-space albeit with reduced temporal resolution. 
The purpose of this study was to evaluate whether such a 
‘stack-of-stars’ acquisition can be used with high enough 
resolution for the DCE sequence to provide a complete free 
breathing RT planning protocol in lung patients. 
 
Material and Methods: Institutional review board approval 
was obtained. Two patients receiving lung radiotherapy 
underwent DCE-MRI on our dedicated wide bore 3 Tesla 
system (Skyra, Siemens) using an 18 channel flexible coil and 
32 channel table coil. Patients were positioned as per 
treatment setup with their hands above their head. Two DCE 
protocols were examined; a fast gradient-echo sequence 
employing k-space sharing (TWIST) acquired as 5 breath-hold 
periods of 20s each with a spatial and temporal resolution of 
1.5 mm/3 s; and a completely free breathing scan performed 
using a radial acquisition (StarVIBE) with a resolution of 1.8 
mm and 14 s. The acquisition time was approximately 6 
minutes for both sequences. In both cases a rapid pre-
contrast measurement of T1 was acquired using the same 
sequence and two flip angles. Analysis included calculation of 
T1 map and a two-compartment model fit to the data 
(Tissue4D, Siemens) to provide pixel-by-pixel maps of the 
perfusion rate constant. 
 
Results: Figure 1 shows images and analysis taken from both 
sequences. Viewing DCE data in a cine loop revealed large 
movement between frames for TWIST compared to StarVIBE. 
A comparison of signal-time plots shows a typical result 
where failure to maintain and reproduce breath hold has 
produce large variation and discontinuities in the dataset. As 
a result the goodness-of-fit (chi2) was better for StarVIBE 
(0.05) than the corresponding value using TWIST (0.16). 
Although temporal resolution is much poorer with the 
StarVIBE sequence, it was sufficient to sample the early 
upslope phase of the contrast agent. General image quality 
was assessed with radial and motion artefacts scored as being 
negligible. 
 
Conclusion: These initial results show that use of a radial k-
space trajectory as a method of motion compensation 
provides a DCE scan of sufficient image quality and temporal 
resolution which can be used as part of a complete free 
breathing lung protocol. 
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Purpose or Objective: Radiomic image features derived from 
conventional treatment planning CT images have already 
been shown to have prognostic information. For cone-beam 
CT (CBCT) imaging during radiotherapy this has not yet been 
described. Due to the fact that a CBCT image is acquired 
prior to each fraction it has the potential to monitor response 
to treatment. The goal of this study was to investigate the 
stability and the correlation between radiomic features 
derived from planning CT vs. CBCT and between CBCTs of 
different fractions.  
 
Material and Methods: A total of 27 stage II-III NSCLC 
patients who received radiation therapy were included in this 
study. For each patient a treatment planning CT scan was 
acquired and CBCT scans were obtained prior to each 
fraction. The planning CT (CT1), the CBCT of the first (CBCT-
FX1) and second fraction (CBCT-FX2) were used in this study. 
CBCT images were registered to CT1 using automatic rigid 
registration prior to feature extraction. In total, 149 radiomic 
image features were extracted of different feature groups: I) 
tumor intensity, II) texture, III) Laplacian of Gaussian. The 
third group consists of filtered first order features and the 
group was subdivided into 10 groups, according to different 
LoG filter standard deviations ranging from 0.5 mm to 5 mm 
with a 0.5 mm interval. Since a rigid registration was used, 
features related to shape and volume were not analyzed. The 
correlation between features derived from (1) CT1 and CBCT-
FX1 and (2) CBCT-FX1 and CBCT-FX2 were analyzed. 
Correlations were calculated using an intraclass correlation 
coefficient ICC(2,1). An ICC-value above 0.9 was considered a 
good agreement. 
 
Results: For 26% of the 149 analyzed radiomics features, the 
ICC-value was higher than 0.9 for CT1 compared to CBCT-FX1 
(Figure). The ICC-value was above 0.9 for 81% of the features 
when comparing CBCT-FX1 to CBCT-FX2. Specifically for the 
feature group ‘texture’, one of the 44 features had an 
agreement between CT1 and CBCT-FX1 that was higher than 
0.9, but 35 out of 44 did show agreement for CBCT-FX1 vs. 
CBCT-FX2. For ‘tumor intensity’, 2 out of 15 features showed 
a large correlation between CT1 and CBCT-FX1 higher than 
0.9, whereas 10 out of 15 features showed agreement higher 
than 0.9 between CBCT-FX1 and CBCT-FX2 (ICC>0.8 for all). 
All features with ICC above 0.9 for CT1 vs. CBCT-FX1 also 
showed high correlation between CBCT-FX1 and CBCT-FX2. 
